PRNAF OTC
Alterity Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: +627.3%
YTD: +6249.2%
1Y: +13233.3%
3Y: +7447.2%
5Y: +1631.6%
$0.40
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$22M
-96.4% ▼
Capital Expenditures
$22M
+2249177400.0% ▲
5Y CAGR: +495.6%
Free Cash Flow
$0
+100.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$6M
-71.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$13M | -$14M | -$19M | -$12M | -$23M |
| Depreciation & Amort. | $54K | $102K | $148K | $140K | $0 |
| Stock-Based Comp. | $2M | $967K | $882K | $980K | $0 |
| Change in Working Capital | $2M | -$6M | $5M | -$614K | -$4M |
| Other Non-Cash Items | $61 | -$907K | $841K | $191K | $5M |
| Operating Cash Flow | -$12M | -$20M | -$13M | -$11M | -$22M |
| — Investing Activities — | |||||
| Capital Expenditures | -$89K | -$7K | -$6K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$8M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $7M |
| Other Investing | $0 | -$29K | $0 | $0 | $0 |
| Investing Cash Flow | -$89K | -$36K | -$6K | -$8M | $7M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$35K | -$60K | -$10K | -$127K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$837K | -$132K | -$918K | -$3M | -$136K |
| Financing Cash Flow | $16M | $124K | $9M | $40M | $19M |
| Net Change in Cash | $7M | -$19M | -$3M | $21M | $6M |
| Cash End of Period | $35M | $16M | $13M | $33M | $37M |
| Free Cash Flow | -$12M | -$20M | -$13M | -$11M | $0 |